Gilead Is Said to Hold Arcus Stake Talks, Spurring 54% Rally

(Bloomberg) — Gilead Sciences Inc. is considering acquiring a stake in Arcus Biosciences Inc., a cancer therapeutics company backed by Alphabet Inc., people familiar with the matter said.The companies have held discussions about Gilead taking a significant stake in the Hayward, California-based company, and also about possible development partnerships, said the people, who asked not to be identified as the details are private.Arcus shares jumped as much as 54% after the close of regular trading Wednesday. Earlier in the day, the shares fell 7.2% to $15.58 in New York during the regular trading session, giving the company a market value …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.